AI-Powered Brain Implants Will Treat Brain Cancer | Ben Woodington
Coherence Neuro co-founder and CEO Ben Woodington discusses the company's $45M Series A round led by Founders Fund and the OpenAI Startup Fund to develop brain-computer interfaces (BCIs) that interface with biology to treat brain cancer. He explains how brain tumors bidirectionally communicate with the nervous system, how AI accelerates neurotech output 5x, and the future of consumer brain implants over the next decade. Check out our sponsor Lovable: https://lovable.dev. Turn ideas into software people love.
MTS is a live news and interview show covering technology, business, politics, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.